Peptide therapy for allergic diseases: Basic mechanisms and new clinical approaches

Pharmacology and Therapeutics

Volumn 108, Issue 3, 2005, Pages 353-361

  Larché, Mark ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Asthma; Epitope; Immunological tolerance; Immunology; Major histocompatibility complex

Indexed keywords

ALLERGEN; API M 1 PEPTIDE; CD4 ANTIGEN; CYTOKINE; EPITOPE; FEL D 1 PEPTIDE; GAMMA INTERFERON; IMMUNOGLOBULIN E; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 4; PEPTIDE DERIVATIVE; UNCLASSIFIED DRUG;

ALLERGIC DISEASE; ANTIGEN ANTIBODY REACTION; ASTHMA; BLOOD CELL; BRONCHUS HYPERREACTIVITY; CELL FUNCTION; CELL PROLIFERATION; CLINICAL TRIAL; CROSS REACTION; FORCED EXPIRATORY VOLUME; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOTHERAPY; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE;

ALLERGENS; ANIMALS; DESENSITIZATION, IMMUNOLOGIC; HUMANS; HYPERSENSITIVITY; PEPTIDES;

EID: 28044448543     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2005.05.004     Document Type: Review

References (69)

1. C.A. Akdis, and K. Blaser Role of IL-10 in allergen-specific immunotherapy and normal response to allergens Microbes Infect 3 2001 891 898
2. C.A. Akdis, M. Akdis, T. Blesken, D. Wymann, S.S. Alkan, and U. Muller Epitope-specific T cell tolerance to phospholipase A2 in bee venom immunotherapy and recovery by IL-2 and IL-15 in vitro J Clin Invest 98 1996 1676 1683
3. M. Akdis, J. Verhagen, A. Taylor, F. Karamloo, C. Karagiannidis, and R. Crameri Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells J Exp Med 199 2004 1567 1575
4. C. Alexander, W.L. Oldfield, K. Shirley, M. Larche, and A.B. Kay A dosing protocol of allergen-derived T cell peptide epitopes for the treatment of allergic disease J Allergy Clin Immunol 107 2001 176
5. C. Alexander, S. Ying, B. Kay, and M. Larche Fel d 1-derived T cell peptide therapy induces recruitment of CD4CD25; CD4 interferon-gamma T helper type 1 cells to sites of allergen-induced late-phase skin reactions in cat-allergic subjects Clin Exp Allergy 35 1 2005 52 58
6. F.R. Ali, W.L. Oldfield, N. Higashi, M. Larche, and A.B. Kay Late asthmatic reactions induced by inhalation of allergen-derived T cell peptides Am J Respir Crit Care Med 169 2004 20 26
7. S.M. Anderton, Z.R. van Der, B. Prakken, A. Noordzij, and W. van Eden Activation of T cells recognizing self 60-kD heat shock protein can protect against experimental arthritis J Exp Med 181 1995 943 952
8. S.M. Anderton, C. Burkhart, G.Y. Liu, B. Metzler, and D.C. Wraith Antigen-specific tolerance induction and the immunotherapy of experimental autoimmune disease Novartis Found Symp 215 1998 120 131
9. M. Astori, C. von Garnier, A. Kettner, N. Dufour, G. Corradin, and F. Spertini Inducing tolerance by intranasal administration of long peptides in naive and primed CBA/J mice J Immunol 165 2000 3497 3505
10. L. Bauer, B. Bohle, B. Jahn-Schmid, U. Wiedermann, A. Daser, and H. Renz Modulation of the allergic immune response in BALB/c mice by subcutaneous injection of high doses of the dominant T cell epitope from the major birch pollen allergen Bet v 1 Clin Exp Immunol 107 1997 536 541
11. B. Bielekova, B. Goodwin, N. Richert, I. Cortese, T. Kondo, and G. Afshar Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand Nat Med 6 2000 1167 1175
12. T.J. Briner, M.C. Kuo, K.M. Keating, B.L. Rogers, and J.L. Greenstein Peripheral T-cell tolerance induced in naive and primed mice by subcutaneous injection of peptides from the major cat allergen Fel d I Proc Natl Acad Sci U S A 90 1993 7608 7612
13. C. Burkhart, G.Y. Liu, S.M. Anderton, B. Metzler, and D.C. Wraith Peptide-induced T cell regulation of experimental autoimmune encephalomyelitis: a role for IL-10 Int Immunol 11 1999 1625 1634
14. J.P. Clayton, G.M. Gammon, D.G. Ando, D.H. Kono, L. Hood, and E.E. Sercarz Peptide-specific prevention of experimental allergic encephalomyelitis. Neonatal tolerance induced to the dominant T cell determinant of myelin basic protein J Exp Med 169 1989 1681 1691
15. P.S. Creticos, J.J. Eiden, S. Balcer, G. Van Nest, A. Kagey-Sobotka, and S. Tuck Immunostimulatory oligonucleotides conjugated to Amb a 1: safety, skin test reactivity and basophil histamine release J Allergy Clin Immunol 105 1 2000, January S70 (Abstract)
16. S.R. Durham, S. Ying, V.A. Varney, M.R. Jacobson, R.M. Sudderick, and I.S. Mackay Grass pollen immunotherapy inhibits allergen-induced infiltration of CD4+ T lymphocytes and eosinophils in the nasal mucosa and increases the number of cells expressing messenger RNA for interferon-gamma J Allergy Clin Immunol 97 1996 1356 1365
17. S.R. Durham, S.M. Walker, E.M. Varga, M.R. Jacobson, F. O'Brien, and W. Noble Long-term clinical efficacy of grass-pollen immunotherapy N Engl J Med 341 1999 468 475
18. F. Ferreira, K. Hirtenlehner, A. Jilek, J. Godnik-Cvar, H. Breiteneder, and R. Grimm Dissection of immunoglobulin E and T lymphocyte reactivity of isoforms of the major birch pollen allergen Bet v 1: potential use of hypoallergenic isoforms for immunotherapy J Exp Med 183 1996 599 609
19. A. Gaur, B. Wiers, A. Liu, J. Rothbard, and C.G. Fathman Amelioration of autoimmune encephalomyelitis by myelin basic protein synthetic peptide-induced anergy Science 258 1992 1491 1494
20. H. Groux, M. Bigler, J.E. de Vries, and M.G. Roncarolo Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells J Exp Med 184 1996 19 29
21. M. Hage-Hamsten, M. Kronqvist, O. Zetterstrom, E. Johansson, V. Niederberger, and S. Vrtala Skin test evaluation of genetically engineered hypoallergenic derivatives of the major birch pollen allergen, Bet v 1: results obtained with a mix of two recombinant Bet v 1 fragments and recombinant Bet v 1 trimer in a Swedish population before the birch pollen season J Allergy Clin Immunol 104 1999 969 977
22. Q.A. Hamid, E. Schotman, M.R. Jacobson, S.M. Walker, and S.R. Durham Increases in IL-12 messenger RNA+ cells accompany inhibition of allergen-induced late skin responses after successful grass pollen immunotherapy J Allergy Clin Immunol 99 1997 254 260
23. B.M. Haselden, A.B. Kay, and M. Larche Immunoglobulin E-independent major histocompatibility complex-restricted T cell peptide epitope-induced late asthmatic reactions J Exp Med 189 1999 1885 1894
24. B.M. Haselden, E. Syrigou, M. Jones, D. Huston, K. Ichikawa, and M.D. Chapman Proliferation and release of IL-5 and IFN-gamma by peripheral blood mononuclear cells from cat-allergic asthmatics and rhinitics, non-cat-allergic asthmatics, and normal controls to peptides derived from Fel d 1 chain 1 J Allergy Clin Immunol 108 2001 349 356
25. G.F. Hoyne, R.E. O'Hehir, D.C. Wraith, W.R. Thomas, and J.R. Lamb Inhibition of T cell and antibody responses to house dust mite allergen by inhalation of the dominant T cell epitope in naive and sensitized mice J Exp Med 178 1993 1783 1788
26. G.F. Hoyne, B.A. Askonas, C. Hetzel, W.R. Thomas, and J.R. Lamb Regulation of house dust mite responses by intranasally administered peptide: transient activation of CD4+ T cells precedes the development of tolerance in vivo Int Immunol 8 1996 335 342
27. P. Jeannin, S. Lecoanet, Y. Delneste, J.F. Gauchat, and J.Y. Bonnefoy IgE versus IgG4 production can be differentially regulated by IL-10 J Immunol 160 1998 3555 3561
28. M. Jutel, M. Akdis, F. Budak, C. Aebischer-Casaulta, M. Wrzyszcz, and K. Blaser IL-10 and TGF-beta cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy Eur J Immunol 33 2003 1205 1214
29. L. Kappos, G. Comi, H. Panitch, J. Oger, J. Antel, and P. Conlon Induction of a non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo-controlled, randomized phase II trial. The Altered Peptide Ligand in relapsing MS Study Group Nat Med 6 2000 1176 1182
30. G. Ku, M. Kronenberg, D.J. Peacock, P. Tempst, M.L. Banquerigo, and B.S. Braun Prevention of experimental autoimmune arthritis with a peptide fragment of type II collagen Eur J Immunol 23 1993 591 599
31. J.R. Lamb, B.J. Skidmore, N. Green, J.M. Chiller, and M. Feldmann Induction of tolerance in influenza virus-immune T lymphocyte clones with synthetic peptides of influenza hemagglutinin J Exp Med 157 1983 1434 1447
32. M. Larche, and D.C. Wraith Peptide-based therapeutic vaccines for allergic and autoimmune diseases Nat Med 11 2005 S69 S76
33. E.M. Ling, T. Smith, X.D. Nguyen, C. Pridgeon, M. Dallman, and J. Arbery Relation of CD4+CD25+ regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease Lancet 363 2004 608 615
34. P. Maguire, C. Nicodemus, D. Robinson, D. Aaronson, and D.T. Umetsu The safety and efficacy of ALLERVAX CAT in cat allergic patients Clin Immunol 93 1999 222 231
35. G.V. Marcotte, C.M. Braun, P.S. Norman, C.F. Nicodemus, A. Kagey-Sobotka, and L.M. Lichtenstein Effects of peptide therapy on ex vivo T-cell responses J Allergy Clin Immunol 101 1998 506 513
36. D.G. Marsh Preparation and properties of allergoids, derived from native pollen allergens by mild formalin treatment Int Arch Allergy Appl Immunol 41 1971 199 215
37. D.G. Marsh, L.M. Lichtenstein, and D.H. Campbell Studies on "allergoids" prepared from naturally occurring allergens: I. Assay of allergenicity and antigenicity of formalinized rye group I component Immunology 18 1970 705 722
38. B. Metzler, and D.C. Wraith Immunotherapy of autoimmune disease with synthetic peptides Immunol Today 15 1994 91
39. F. Monneaux, and S. Muller Peptide-based immunotherapy of systemic lupus erythematosus Autoimmun Rev 3 2004 16 24
40. F. Monneaux, J.M. Lozano, M.E. Patarroyo, J.P. Briand, and S. Muller T cell recognition and therapeutic effect of a phosphorylated synthetic peptide of the 70K snRNP protein administered in MR/lpr mice Eur J Immunol 33 2003 287 296
41. U. Muller, C.A. Akdis, M. Fricker, M. Akdis, T. Blesken, and F. Bettens Successful immunotherapy with T-cell epitope peptides of bee venom phospholipase A2 induces specific T-cell anergy in patients allergic to bee venom J Allergy Clin Immunol 101 1998 747 754
42. L. Noon Prophylactic innoculation against hay fever Lancet i 1911 1572 1573
43. P.S. Norman, J.L. Ohman Jr., A.A. Long, P.S. Creticos, M.A. Gefter, and Z. Shaked Treatment of cat allergy with T-cell reactive peptides Am J Respir Crit Care Med 154 1996 1623 1628
44. K.T. Nouri-Aria, P.A. Wachholz, J.N. Francis, M.R. Jacobson, S.M. Walker, and L.K. Wilcock Grass pollen immunotherapy induces mucosal and peripheral IL-10 responses and blocking IgG activity J Immunol 172 2004 3252 3259
45. N. Novak, T. Bieber, and N. Katoh Engagement of Fc epsilon RI on human monocytes induces the production of IL-10 and prevents their differentiation in dendritic cells J Immunol 167 2001 797 804
46. T. Okada, I. Swoboda, P.L. Bhalla, K. Toriyama, and M.B. Singh Engineering of hypoallergenic mutants of the Brassica pollen allergen, Bra r 1, for immunotherapy FEBS Lett 434 1998 255 260
47. W.L. Oldfield, A.B. Kay, and M. Larche Allergen-derived T cell peptide-induced late asthmatic reactions precede the induction of antigen-specific hyporesponsiveness in atopic allergic asthmatic subjects J Immunol 167 2001 1734 1739
48. W.L. Oldfield, M. Larche, and A.B. Kay Effect of T-cell peptides derived from Fel d 1 on allergic reactions and cytokine production in patients sensitive to cats: a randomised controlled trial Lancet 360 2002 47 53
49. G. Pauli, A. Purohit, J.P. Oster, F. de Blay, S. Vrtala, and V. Niederberger Comparison of genetically engineered hypoallergenic rBet v 1 derivatives with rBet v 1 wild-type by skin prick and intradermal testing: results obtained in a French population Clin Exp Allergy 30 2000 1076 1084
50. J. Pene, A. Desroches, L. Paradis, B. Lebel, M. Farce, and C.F. Nicodemus Immunotherapy with Fel d 1 peptides decreases IL-4 release by peripheral blood T cells of patients allergic to cats J Allergy Clin Immunol 102 1998 571 578
51. B.J. Prakken, Z.R. van Der, S.M. Anderton, P.J. van Kooten, W. Kuis, and W. van Eden Peptide-induced nasal tolerance for a mycobacterial heat shock protein 60 T cell epitope in rats suppresses both adjuvant arthritis and nonmicrobially induced experimental arthritis Proc Natl Acad Sci U S A 94 1997 3284 3289
52. B.J. Prakken, S. Roord, P.J. van Kooten, J.P. Wagenaar, W. van Eden, and S. Albani Inhibition of adjuvant-induced arthritis by interleukin-10-driven regulatory cells induced via nasal administration of a peptide analog of an arthritis-related heat-shock protein 60 T cell epitope Arthritis Rheum 46 2002 1937 1946
53. B.J. Prakken, R. Samodal, T.D. Le, F. Giannoni, G.P. Yung, and J. Scavulli Epitope-specific immunotherapy induces immune deviation of proinflammatory T cells in rheumatoid arthritis Proc Natl Acad Sci U S A 101 2004 4228 4233
54. B. Royer, S. Varadaradjalou, P. Saas, J.J. Guillosson, J.P. Kantelip, and M. Arock Inhibition of IgE-induced activation of human mast cells by IL-10 Clin Exp Allergy 31 2001 694 704
55. L. Santambrogio, A.K. Sato, G.J. Carven, S.L. Belyanskaya, J.L. Strominger, and L.J. Stern Extracellular antigen processing and presentation by immature dendritic cells Proc Natl Acad Sci U S A 96 1999 15056 15061
56. L. Santambrogio, A.K. Sato, F.R. Fischer, M.E. Dorf, and L.J. Stern Abundant empty class II MHC molecules on the surface of immature dendritic cells Proc Natl Acad Sci U S A 96 1999 15050 15055
57. H. Secrist, C.J. Chelen, Y. Wen, J.D. Marshall, and D.T. Umetsu Allergen immunotherapy decreases interleukin 4 production in CD4+ T cells from allergic individuals J Exp Med 178 1993 2123 2130
58. F.E. Simons, M. Imada, Y. Li, W.T. Watson, and K.T. HayGlass Fel d 1 peptides: effect on skin tests and cytokine synthesis in cat-allergic human subjects Int Immunol 8 1996 1937 1945
59. N.A. Staines, N. Harper, F.J. Ward, V. Malmstrom, R. Holmdahl, and S. Bansal Mucosal tolerance and suppression of collagen-induced arthritis (CIA) induced by nasal inhalation of synthetic peptide 184-198 of bovine type II collagen (CII) expressing a dominant T cell epitope Clin Exp Immunol 103 1996 368 375
60. M. Stienekemeier, K. Falk, O. Rotzschke, A. Weishaupt, C. Schneider, and K.V. Toyka Vaccination, prevention, and treatment of experimental autoimmune neuritis (EAN) by an oligomerized T cell epitope Proc Natl Acad Sci U S A 98 2001 13872 13877
61. C. Texier, S. Pouvelle, M. Busson, M. Herve, D. Charron, and A. Menez HLA-DR restricted peptide candidates for bee venom immunotherapy J Immunol 164 2000 3177 3184
62. J.H. van Bilsen, J.P. Wagenaar-Hilbers, M.J. van der Cammen, M.E. van Dijk, W. van Eden, and M.H. Wauben Successful immunotherapy with matrix metalloproteinase-derived peptides in adjuvant arthritis depends on the timing of peptide administration Arthritis Res 4 2002 R2
63. V.A. Varney, M. Gaga, A.J. Frew, V.R. Aber, A.B. Kay, and S.R. Durham Usefulness of immunotherapy in patients with severe summer hay fever uncontrolled by antiallergic drugs BMJ 302 1991 265 269
64. V.A. Varney, Q.A. Hamid, M. Gaga, S. Ying, M. Jacobson, and A.J. Frew Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late-phase cutaneous responses J Clin Invest 92 1993 644 651
65. A. Verhoef, C. Alexander, A.B. Kay, and M. Larche T cell epitope immunotherapy induces a CD4(+) T cell population with regulatory activity PLoS Med 2 2005 e78
66. L. Vidard, L.J. Colarusso, and B. Benacerraf Specific T-cell tolerance may be preceded by a primary response Proc Natl Acad Sci U S A 91 1994 5627 5631
67. S. Vrtala, K. Hirtenlehner, M. Susani, P. Hufnagl, B.R. Binder, and L. Vangelista Genetic engineering of recombinant hypoallergenic oligomers of the major birch pollen allergen, Bet v 1: candidates for specific immunotherapy Int Arch Allergy Immunol 118 1999 218 219
68. K.G. Warren, I. Catz, and K.W. Wucherpfennig Tolerance induction to myelin basic protein by intravenous synthetic peptides containing epitope P85 VVHFFKNIVTP96 in chronic progressive multiple sclerosis J Neurol Sci 152 1997 31 38
69. S. Webb, C. Morris, and J. Sprent Extrathymic tolerance of mature T cells: clonal elimination as a consequence of immunity Cell 63 1990 1249 1256